Yang Zeyuan, Hui Vicki Wing-Ki, Yip Terry Cheuk-Fung, Lai Mandy Sze-Man, Lai Jimmy Che-To, Wong Vincent Wai-Sun, Cheung Ramsey, Wong Grace Lai-Hung, Wong Robert J
Gastroenterology and Hepatology Section, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA, USA.
Medical Data Analytics Centre (MDAC), State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
JHEP Rep. 2024 Oct 31;7(1):101254. doi: 10.1016/j.jhepr.2024.101254. eCollection 2025 Jan.
BACKGROUND & AIMS: Alcohol-associated liver disease (ALD) burden has been rising globally, fueled by increases in high-risk alcohol use following the coronavirus disease 2019 (COVID-19) pandemic. We evaluated trends in annual incidence of alcohol-associated hepatitis (AH) before and following the onset of the COVID-19 pandemic across two geographically distinct populations in the USA and Hong Kong.
Using US national Veterans Affairs (VA) data and Hong Kong territory-wide data, trends in annual incidence of AH were evaluated from 2000 to 2023. AH was identified using a combination of International Classification of Diseases (ICD)-9/10 diagnostic codes, laboratory data, and available alcohol use data.
Among the VA data, annual incidence of AH rose steadily from 39.4 to 53.7 per 100,000 persons (2010-2020), then declined to 36.2 per 100,000 persons in 2023. Annual AH incidence was substantially lower in Hong Kong, but demonstrated similar trends, peaking at 0.28 per 100,000 persons during the first year of the pandemic. Among both cohorts, incidence of AH was significantly higher in men . women, but particularly for the VA cohort, the increase in AH incidence was more rapid in women. Among both cohorts, the highest incidence of AH in 2023 was among the 40-49-year age group (VA: 72.7 per 100,000 persons; Hong Kong: 1.89 per 100,000 persons).
We provide a comprehensive analysis of epidemiological trends in AH incidence across two distinct populations, highlighting the need for continued awareness of targeted interventions to curb unhealthy alcohol use and its complications.
Alcohol-associated hepatitis (AH) is a severe complication of high-risk alcohol use associated with significant morbidity and mortality. Increasing alcohol use fueled by the COVID-19 pandemic has led to parallel increases in alcohol-related comorbidities. The current study provides a comprehensive analysis of trends in the incidence of AH across two distinct world regions before and following the onset of the COVID-19 pandemic. Better identification of epidemiological trends in AH incidence as well as highlighting populations most affected can help target public health resources and health system interventions to address the dangers of high-risk alcohol use more effectively.
在2019冠状病毒病(COVID-19)大流行后,高风险饮酒行为增加,推动全球酒精性肝病(ALD)负担不断上升。我们评估了美国和香港两个地理位置不同的人群在COVID-19大流行前后酒精性肝炎(AH)的年发病率趋势。
利用美国退伍军人事务部(VA)的全国数据和香港全地区的数据,评估2000年至2023年AH的年发病率趋势。使用国际疾病分类(ICD)-9/10诊断代码、实验室数据和可用的饮酒数据相结合的方法来识别AH。
在VA数据中,AH的年发病率从每10万人39.4例稳步上升至53.7例(2010 - 2020年),然后在2023年降至每10万人36.2例。香港的AH年发病率显著较低,但呈现出类似趋势,在大流行的第一年达到每10万人0.28例的峰值。在两个队列中,男性的AH发病率均显著高于女性,但特别是在VA队列中,女性的AH发病率上升更为迅速。在两个队列中,2023年AH发病率最高的是40 - 49岁年龄组(VA:每10万人72.7例;香港:每10万人1.89例)。
我们对两个不同人群中AH发病率的流行病学趋势进行了全面分析,强调需要持续关注有针对性的干预措施,以遏制不健康饮酒行为及其并发症。
酒精性肝炎(AH)是高风险饮酒的严重并发症,与显著的发病率和死亡率相关。COVID-19大流行导致饮酒增加,进而使酒精相关的合并症平行增加。本研究对COVID-19大流行前后两个不同世界地区的AH发病率趋势进行了全面分析。更好地识别AH发病率的流行病学趋势以及突出受影响最严重的人群,有助于更有效地将公共卫生资源和卫生系统干预措施针对高风险饮酒的危害。